Treatment with biologic disease-modifying antirheumatic drugs (bDMARDs), particularly tocilizumab, can suppress inflammation and preserve renal function in a majority of patients with chronic ...
One of the most serious complications of rheumatologic and autoimmune diseases can be prevented with biologic drugs, a single-center chart review suggested, and some such products may be more ...
FDA Authorizes Device for Dialysis-Related Amyloidosis Patient and graft survival rates were 85.5% and 75.8%, respectively, at 5 years. New study findings support kidney transplantation to treat ...
(Boston) – Serum amyloid A (SAA) is a family of ancient proteins that can be traced from present-day humans back half a billion years to sea cucumbers and oysters. A new study by researchers from the ...
DEAR DR. ROACH: I recently saw a friend who had been diagnosed with ALECT2 amyloidosis, a form of chronic kidney disease that is not well-understood but is considered fatal. Her illness was first ...
Primary (AL) amyloidosis is the most prevalent type of systemic amyloidosis, and management of this disease has evolved through the years from supportive care to aggressive treatments that include ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results